Overview

As one of PC-TRiADD’s key services, the Laboratory for Advanced Genome Analysis (LAGA) offers rapid, economical, tailored microarray, sequencing and bioinformatics expertise to small or large-scale projects. Serving academic and private sector groups, our highly trained personnel will provide recommendations to ensure the best possible use of genomics and transcriptomics technology. We also offer solutions for the profiling of FFPE tissues and a complete, project-tailored downstream bioinformatics analysis of microarray and sequencing data.

LAGA offers economically priced services based on a cost-recovery, not-for-profit model. Our ongoing internal and external collaborations allow our facility to continually improve and expand both its R&D capabilities, and its access to state-of-the-art equipment and software, which in turn, benefits our clients.

BGI, the world's largest genomics organization, based in China, and the Vancouver Prostate Centre (VPC), a global leader in translational research in cancer, have established the BGI-VPC Joint Research Laboratory. This sequencing and translational research facility, located in LAGA, will discover and advance basic and translational programs in oncology, including precision oncology. The collaboration, the first between BGI and any Canadian research institution, will change the landscape of genomic and translational research across Canada and benefit patients worldwide.

News

Sep 29 2014

Prostate Cancer Canada Translational Acceleration Grant awarded to Drs. Rennie, Cherkasov and Tomlinson-Guns

September 26, 2014 - Prostate Cancer Canada today annouced the results of their funding decision in their Translation Acceleration Grant competition TAG2: Novel Therapeutics for Advanced Disease.  This funding is for groups studying novel therapeutics and treatment options for metastatic and castrate-resistant prostate cancer, for  projects aimed at eliminating advanced disease from affected men. Co-lead by Drs.

Read more
Sep 12 2014

BGI and the Vancouver Prostate Centre Announce Partnership to Create Joint Research Laboratory for Advancement of Translational Cancer Research

SHENZHEN, China and VANCOUVER, British Columbia, September 12, 2014 – BGI, the world’s largest genomics organization, based in China, and The Vancouver Prostate Centre (VPC), a global leader in translational research in cancer, today announced the establishment of the BGI-VPC Joint Research Laboratory, a sequencing and translational research facility, to jointly discover and advance basic and translational programs in oncology, including precision oncology.

Read more
Aug 25 2014

New National Health Sciences Accelerator, Accel-Rx Formally Launched as a Centre of Excellence for Commercialization and Research

With the awarding of $14.5M under the Canadian government’s Networks of Centres of Excellence (Centres of Excellence for Commercialization and Research (CECR)) Program, as announced earlier this morning by the Honourable Ed Holder, Minister of State for Science and Technology, Accel-Rx - Canada’s Health Sciences Accelerator is officially launched.The Accel-Rx Health Sciences Accelerator is a national organization focused on maximizing new health sciences company creation, and ensuring start-ups have the resources they need to enable them to stay and grow in Canada and give rise to a new gen

Read more